Loss of bone mineral density and secondary hyperparathyroidism are complications of autologous stem cell transplantation

Leukemia and Lymphoma

Volumn 48, Issue 5, 2007, Pages 923-930

  Ria, Roberto ^a   Scarponi, Anna Maria ^b   Falzetti, Franca ^b   Ballanti, Stelvio ^b   Di Ianni, Mauro ^b   Sportoletti, Paolo ^b   Cimminiello, Michele ^b   Gasbarrino, Cristiana ^b   Pallone, Benedetta ^b   Vacca, Angelo ^a   Dammacco, Franco ^a   Mannarino, Elmo ^b   Tabilio, Antonio ^b  

^a UNIVERSITY OF BARI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Autologous bone marrow transplantation; Bone mineral density; Hematologic malignancies; Hyperparathyroidism

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; BUSULFAN; CALCIUM; CARBOPLATIN; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IDARUBICIN; MELPHALAN; MITOXANTRONE; PREDNISONE; RITUXIMAB; THIOTEPA; VINBLASTINE; VINCRISTINE; VITAMIN D;

ACUTE LEUKEMIA; ADULT; AGED; ARTICLE; AUTOLOGOUS STEM CELL TRANSPLANTATION; BONE DENSITY; BONE MASS; BONE MINERAL; BONE TURNOVER; CANCER CHEMOTHERAPY; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; DRUG MEGADOSE; FEMALE; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HODGKIN DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; SECONDARY HYPERPARATHYROIDISM; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BONE AND BONES; BONE DENSITY; BONE DISEASES, METABOLIC; FEMALE; HEMATOLOGIC NEOPLASMS; HUMANS; HYPERPARATHYROIDISM; MALE; MIDDLE AGED; OSTEOPOROSIS; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 34547452582     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190701268775     Document Type: Article

References (41)

1. Zittoun, R. A., Mandelli, F., Willemze, R., de Witte, T., Labar, B. and Resegotti, L. (1995) Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med, 332, pp. 217-223.
2. Dann, E. J., Daugherty, C. K. and Larson, R. A. (1997) Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplant, 20, pp. 369-374.
3. Verdonck, L. F., Dekker, A. W., Lokhorst, H. M., Petersen, E. J. and Nieuwenhuis, H. K. (1997) Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma. Blood, 90, pp. 4201-4205.
4. Rehman, Q. and Lane, N. E. (2003) Effect of glucocorticoids on bone density. Med Pediatr Oncol, 41, pp. 212-216.
5. Theiler, R., Kranzlin, M., Zynamon, A., Tyndall, A. and Schmid, H. P. (1995) High-turnover osteoporosis and diffuse idiopathic skeletal hyperostosis induced by retinoid therapy in a patient with superficial bladder cancer. Br J Urol, 76, pp. 400-401.
6. Cohen, A. and Shane, E. (2003) Osteoporosis after solid organ and bone marrow transplantation. Osteoporos Int, 14, pp. 617-630.
7. Bush, N. E., Donaldson, G. W., Haberman, M. H., Dacanay, R. and Sullivan, K. M. (2000) Conditional and unconditional estimation of multidimensional quality of life after hematopoietic stem cell transplantation: A longitudinal follow-up of 415 patients. Biol Blood Marrow Transplant, 6, pp. 576-591.
8. Banfi, A., Bianchi, G., Galotto, M., Cancedda, R. and Quarto, R. (2001) Bone marrow stromal damage after chemo/radiotherapy: Occurrence, consequences and possibilities of treatment. Leuk Lymphoma, 42, pp. 863-870.
9. Rivkees, S. A. and Crawford, J. D. (1988) The relationship of gonadal activity and chemotherapy-induced gonadal damage. JAMA, 259, pp. 2123-2125.
10. Ferretti, J. L., Cointry, G. R., Capozza, R. F. and Frost, H. M. (2003) Bone mass, bone strength, muscle-bone interactions, osteopenias and osteoporoses. Mech Ageing Dev, 124, pp. 269-279.
11. Adami, S., Giannini, S., Giorgino, R., Isaia, G. C., Maggi, S. and Sinigaglia, L. (2003) The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: The ESOPO study. Osteoporos Int, 14, pp. 198-207.
12. Diamond, T., Levy, S., Day, P., Barbagallo, S., Manoharan, A. and Kwan, Y. K. (1997) Biochemical, histomorphometric and densitometric changes in patients with multiple myeloma: Effects of glucocorticoid therapy and disease activity. Br J Haematol, 97, pp. 641-648.
13. Schulte, C. and Beelen, D. W. (2000) Bone loss in long-term survivors after transplantation of hematopoietic stem cells: A prospective study. Osteoporos Int, 11, pp. 344-353.
14. Schulte, C. M. and Beelen, D. W. (2004) Bone loss following hematopoietic stem cell transplantation: A long-term follow-up. Blood, 103, pp. 3635-3643.
15. Tauchmanova, L., Serio, B., Puente, A Del, Risitano, A. M., Esposito, A. and De Rosa, G. (2002) Long-lasting bone damage detected by dual-energy X-ray absorptiometry, phalangeal osteosonogrammetry, and in vitro growth of marrow stromal cells after allogeneic stem cell transplantation. J Clin Endocrinol Metab, 87, pp. 5058-5065.
16. Crandall, C. (2002) Parathyroid hormone for treatment of osteoporosis. Arch Intern Med, 162, pp. 2297-2309.
17. Kanis, J. A. (1994) Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: Synopsis of a WHO report. WHO Study Group. Osteoporos Int, 4, pp. 368-381.
18. Stern, J. M., Sullivan, K. M., Ott, S. M., Seidel, K., Fink, J. C. and Longton, G. (2001) Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biol Blood Marrow Transplant, 7, pp. 257-264.
19. Schimmer, A. D., Mah, K., Bordeleau, L., Cheung, A., Ali, V. and Falconer, M. (2001) Decreased bone mineral density is common after autologous blood or marrow transplantation. Bone Marrow Transplant, 28, pp. 387-391.
20. Gandhi, M. K., Lekamwasam, S., Inman, I., Kaptoge, S., Sizer, L. and Love, S. (2003) Significant and persistent loss of bone mineral density in the femoral neck after haematopoietic stem cell transplantation: Long-term follow-up of a prospective study. Br J Haematol, 121, pp. 462-468.
21. Buchs, N., Helg, C., Collao, C., Chapuis, B., Slosman, D. and Bonjour, J. P. (2001) Allogeneic bone marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos Int, 12, pp. 880-886.
22. Brown, J. P. and Josse, R. G. (2002) Scientific Advisory Council of the Osteoporosis Society of Canada. 2002 Clinical practice guidelines for the diagnosis and management of osteoporosis in Canada. CMAJ, 167:10, pp. S1-S34.
23. Stern, J. M., Sullivan, K. M., Ott, S. M., Seidel, K., Fink, J. C. and Longton, G. (2001) Bone density loss after allogeneic hematopoietic stem cell transplantation: A prospective study. Biol Blood Marrow Transplant, 7, pp. 257-264.
24. Lee, W. Y., Baek, K. H., Rhee, E. J., Tae, H. J., Oh, K. W. and Kang, M. I. (2004) Impact of circulating bone-resorbing cytokines on the subsequent bone loss following bone marrow transplantation. Bone Marrow Transplant, 34, pp. 89-94.
25. Kashyap, A., Kandeel, F., Yamauchi, D., Palmer, J. M., Niland, J. C. and Molina, A. (2000) Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective study. Biol Blood Marrow Transplant, 6, pp. 344-351.
26. Tauchmanova, L., Selleri, C., Esposito, M., Somma, C Di, Orio Jr, F. and Bifulco, G. (2003) Beneficial treatment with risedronate in long-term survivors after allogeneic stem cell transplantation for hematological malignancies. Osteoporos Int, 14, pp. 1013-1019.
27. Valimaki, M. J., Kinnunen, K., Volin, L., Tahtela, R., Loyttyniemi, E. and Laitinen, K. (1999) A prospective study of bone loss and turnover after allogeneic bone marrow transplantation: Effect of calcium supplementation with or without calcitonin. Bone Marrow Transplant, 23, pp. 355-361.
28. Cilloni, D., Carlo-Stella, C., Falzetti, F., Sammarelli, G., Regazzi, E. and Colla, S. (2000) Limited engraftment capacity of bone marrow-derived mesenchymal cells following T-cell-depleted hematopoietic stem cell transplantation. Blood, 96, pp. 3637-3643.
29. Lee, W. Y., Cho, S. W., Oh, E. S., Oh, K. W., Lee, J. M. and Yoon, K. H. (2002) The effect of bone marrow transplantation on the osteoblastic differentiation of human bone marrow stromal cells. J Clin Endocrinol Metab, 87, pp. 329-335.
30. Banfi, A., Podesta, M., Fazzuoli, L., Sertoli, M. R., Venturini, M. and Santini, G. (2001) High-dose chemotherapy shows a dose-dependent toxicity to bone marrow osteoprogenitors: A mechanism for post-bone marrow transplantation osteopenia. Cancer, 92, pp. 2419-2428.
31. Withold, W., Wolf, H. H., Kollbach, S., Heyll, A., Schneider, W. and Reinauer, H. (1996) Relationship between bone metabolism and plasma cytokine levels in patients at risk of post-transplantation bone disease after bone marrow transplantation. Eur J Clin Chem Clin Biochem, 34, pp. 295-299.
32. Lee, W. Y., Kang, M. I., Oh, E. S., Oh, K. W., Han, J. H. and Cha, B. Y. (2002) The role of cytokines in the changes in bone turnover following bone marrow transplantation. Osteoporos Int, 13, pp. 62-68.
33. Heaf, J., Tvedegaard, E., Kanstrup, I. L. and Fogh-Andersen, N. (2003) Hyperparathyroidism and long-term bone loss after renal transplantation. Clin Transplant, 17, pp. 268-274.
34. Charopoulos, I., Tournis, S., Trovas, G., Raptou, P., Kaldrymides, P. and Skarandavos, G. (2006) Effect of primary hyperparathyroidism on volumetric bone mineral density and bone geometry assessed by peripheral quantitative computed tomography in postmenopausal women. J Clin Endocrinol Metab, 91, pp. 1748-1753.
35. Compston, J. E. (2003) Osteoporosis after liver transplantation. Liver Transplant, 9, pp. 321-330.
36. Carlson, K., Simonsson, B. and Ljunghall, S. (1994) Acute effects of high-dose chemotherapy followed by bone marrow transplantation on serum markers of bone metabolism. Calcif Tissue Int, 55, pp. 408-411.
37. McDonald, J. A., Dunstan, C. R., Dilworth, P., Sherbon, K., Sheil, A. G. and Evans, R. A. (1991) Bone loss after liver transplantation. Hepatology, 14, pp. 613-619.
38. Floreani, A., Fries, W., Luisetto, G., Burra, P., Fagiuoli, S. and Boccagni, P. (1998) Bone metabolism in orthotopic liver transplantation: A prospective study. Liver Transpl Surg, 4, pp. 311-319.
39. Grigg, A. P., Shuttleworth, P., Reynolds, J., Schwarer, A. P., Szer, J. and Bradstock, K. (2006) Pamidronate reduces bone loss after allogeneic stem cell transplantation. J Clin Endocrinol Metab, 91, pp. 3835-3843.
40. Kananen, K., Volin, L., Laitinen, K., Alfthan, H., Ruutu, T. and Valimaki, M. J. (2005) Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab, 90, pp. 3877-3885.
41. Kananen, K., Volin, L., Laitinen, K., Alfthan, H., Ruutu, T. and Valimaki, M. J. (2005) Prevention of bone loss after allogeneic stem cell transplantation by calcium, vitamin D, and sex hormone replacement with or without pamidronate. J Clin Endocrinol Metab, 90, pp. 3877-3885.